MR no. 2014 - 018
6 June 2014
The Financial Markets Authority (FMA) today clarified statements that have apparently been made in communications with shareholders in Abano Healthcare Group Ltd (NZX:ABA).
The FMA has received correspondence, to ABA shareholders, dated 3 June 2014, from Steamboat Capital and Healthcare Industry.
The correspondence cites the FMA in a way which could suggest to shareholders that the FMA has taken formal action, or may yet take action, against ABA regarding financial information released by ABA. Similar statements have been cited in High Court filings.
In light of the imminent extraordinary general meeting for ABA, the Chief Executive of the FMA, Rob Everett, said the FMA was obliged to set straight the public record.
The FMA has no active inquiries underway regarding the firm – ABA - or its current directors. No sanctions at law have been applied to ABA, or the current directors of ABA, by the FMA.
This information (above) has been provided - by the FMA - to ABA, Steamboat Capital, and Healthcare Industry.
At this point, the FMA has no further comment to make on ABA, Steamboat Capital, Healthcare Industry, or the EGM.
Phone: 09 967 1215
Mobile: 021 220 6770